Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
and immune function. By understanding these mechanisms, we aim to identify new opportunities for targeted therapeutic intervention. Bringing together chemical biologists and protein, antibody, and cell
-
to staff position within a Research Infrastructure? No Offer Description Activities and context The fellow will be responsible for the selection of B cells and antibodies from volunteers who have
-
conditions. - Determine the Drug-to-Antibody Ratio (DAR) and characterize the Drug Load Distribution (DLD), when required. - Apply, when appropriate, bottom-up, middle-up/middle-down and top-down strategies
-
engineers recombinant antibodies, related biologics, and reagents for cell-based therapies, and undertakes structural and functional studies of proteins in human health and disease to guide the development
-
reproducibility and high-quality outputs. Collaborate with multidisciplinary teams to advance peptide- and antibody-based drug development programs Undertake other duties as assigned. 5.5 workday per week is
-
equivalencies: https://hr.uky.edu/employment/working-uk/equivalencies Required Related Experience No experience required. Required License/Registration/Certification American Society for Clinical Pathology (ASCP
-
, microfluidic confinement); quantification of isoform distributions; non-conventional large-area patterning of isoforms; functionalization of electrodes for recognition of isoforms and antibodies
-
the project entitled “Personalized antibody-drug conjugates activated by matrix metalloproteinases for solid tumors”, acronym: PACMAN, Virtual Research Institute (WIB); managing entity: Łukasiewicz Research
-
equivalencies: https://hr.uky.edu/employment/working-uk/equivalencies Required Related Experience No experience required. Required License/Registration/Certification American Society for Clinical Pathology (ASCP
-
two referees through this form https://www.um.edu.mt/hrmd/workatum-projects by not later than Monday, 7th September 2026. Late applications will not be considered. Further information may be obtained